The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Looks like BALPA, the pilots Union in BA, have just begun negotiations; I’ve been told that they have a date of 1st June as target. Given BAs history I can see problems ahead as any possible dispute materialises. It seems unlikely that the pilots, like the doctors, will accept any further erosion of their pay!
If this is a private equity bid, I know nothing, then it makes sense. I’m fascinated by the price action, surely this is being held down a reason (funding, tech, buy out). For clarity I’m a substantial holder (in my portfolio). But anything under about £2 is surely ridiculous.
From the 31 August half year report:
‘ We have also made appropriate progress on our commercialisation planning activities, which include medical engagement of pulmonology and radiology thought-leaders at scientific conferences, profiling of our target top-tier academic institutions, and reimbursement code investigation and applications.’
I expect further news on the reimbursement code applications in due course. I can see this to be a requirement for substantial commercial orders (nobody wants a service you can’t charge for).
Expecting this to open at 80p plus. Close on Friday north of 120p.
Anyone expect anything else?
How nice to see a company exceeding market expectations, hope we can push through the pound barrier now and establish a new trading range.
Disappointed they didn’t answer any questions about the recent fund raise and the long dated warrants. Leaves me feeling uncertain about their ability to repay from organic free cash generation and talk of further acquisitions during this year (slide 9) makes me wonder how they will fund these.
From 14/6/22 RNS:
In addition, Verici Dx expects to announce multi-centre clinical validation results for Clarava™, the pre-transplant prognostic test this summer, having completed additional tissue type matching analysis to support the data evaluation.
Summer is coming to an end! News soon surely no later than half year report early September
Been keeping an eye on this share for a while.
Great sector to be in with potential for large growth. However, it is their cash position that worries me, with less than £1M cash it seems a raise is imminent?
This share is my top pick for next 24-36 months. Main risk seems to be one of the large cases loosing in court (Manolete has 100% record; but it could happen).
Really can’t see anything else, bar WW3 or COVID mk2, derailing them. Right place, expansion and market adoption.
Going to be an overhang at 14p obviously. Then on to 20p; smaller overhang with the options. Going to take time, not many meaningful updates but moving in the right direction, operationally..
Both CPC and President look forward to the drilling of the exploration well at the Delray Complex within the Concession. The Company estimates that this complex has 230 million barrels of Pmean unrisked original oil in place. The location of the exploration well within the complex has been identified and planning has begun for the drilling of the well in H1 2022 after the end of the rainy season.
The wettest month of the year is April; July is the driest. Think it would be reasonable to conclude equipment transport and site prep in June followed by spud sometime July. TD end July early August. Any thoughts?
Looks like RAB is backing us. £800,000 + another £1.28M for warrants at 8p, could pay for some of the pilot plant?
Fantastic update!
So, do we know when the closed period will end?
Been researching this for a while and warming to the journey, at this price seems a good risk reward investment.
Will consider taking a position….
Gone very quiet on the proposed spin outs. Guess the market conditions aren’t good at the moment but some update would be nice after all the talk of them being done towards the end of last year!
Barclays broker upgrade, overweight PT 125
Gapped up at bell, nearly 10% up. Bid or position building?
Placing will dilute our holdings by roughly 11.5%. It would seem logical then if they did a ratio of 1 to 10 for the open offer. The kicker will be what upper limit they place on each shareholder. I’m sure that many of us have considerable holding and don’t what to be disadvantaged on that basis!
However, if they go down this route they could potentially raise an additional large sum. For what purpose? Will be interesting to see how we get treated.
Just been going over the operations updates for last year. I’ve noticed that there is no mention of the 3rd drill target in the latest operational update, I hope this does not indicate that it has been cancelled? We were originally hoping for 3-5 new wells.
Another step towards narrowing the gap to NAV.